Literature DB >> 28550079

Getting Out of the Phosphate Bind: Trials to Guide Treatment Targets.

Robert E Olivo1,2, Julia J Scialla3,2.   

Abstract

Entities:  

Keywords:  Biophysical Phenomena; Phosphates

Mesh：

Substances：

Year:  2017        PMID： 28550079      PMCID： PMC5460702          DOI： 10.2215/CJN.04380417

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  18 in total

1.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

2.  Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients.

Authors:  W N Suki; R Zabaneh; J L Cangiano; J Reed; D Fischer; L Garrett; B N Ling; S Chasan-Taber; M A Dillon; A T Blair; S K Burke
Journal:  Kidney Int       Date:  2007-08-29       Impact factor: 10.612

3.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson; Karen M Eddleman; Nicole M Jarrett; Ken LaBresh; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

Review 4.  Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis.

Authors:  Suetonia C Palmer; Armando Teixeira-Pinto; Valeria Saglimbene; Jonathan C Craig; Petra Macaskill; Marcello Tonelli; Giorgia de Berardis; Marinella Ruospo; Giovanni F M Strippoli
Journal:  Am J Kidney Dis       Date:  2015-05-21       Impact factor: 8.860

5.  Lessons in Uncertainty and Humility - Clinical Trials Involving Hypertension.

Authors:  Marc A Pfeffer; John J V McMurray
Journal:  N Engl J Med       Date:  2016-11-03       Impact factor: 91.245

6.  Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

Authors:  Glenn M Chertow; Geoffrey A Block; Ricardo Correa-Rotter; Tilman B Drüeke; Jürgen Floege; William G Goodman; Charles A Herzog; Yumi Kubo; Gerard M London; Kenneth W Mahaffey; T Christian H Mix; Sharon M Moe; Marie-Louise Trotman; David C Wheeler; Patrick S Parfrey
Journal:  N Engl J Med       Date:  2012-11-03       Impact factor: 91.245

7.  The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease.

Authors:  E Slatopolsky; N S Bricker
Journal:  Kidney Int       Date:  1973-08       Impact factor: 10.612

8.  Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial.

Authors:  Ron Wald; Christian G Rabbat; Louis Girard; Amit X Garg; Karthik Tennankore; Jessica Tyrwhitt; Andrew Smyth; Andrea Rathe-Skafel; Peggy Gao; Andrea Mazzetti; Jackie Bosch; Andrew T Yan; Patrick Parfrey; Braden J Manns; Michael Walsh
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-26       Impact factor: 8.237

9.  Phosphate kinetics during high-flux hemodialysis.

Authors:  C A DeSoi; J G Umans
Journal:  J Am Soc Nephrol       Date:  1993-11       Impact factor: 10.121

10.  Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials.

Authors:  Suetonia C Palmer; Sharon Gardner; Marcello Tonelli; Dimitris Mavridis; David W Johnson; Jonathan C Craig; Richard French; Marinella Ruospo; Giovanni F M Strippoli
Journal:  Am J Kidney Dis       Date:  2016-07-22       Impact factor: 8.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.